Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis

Background and Aim: The magnitude of the risk of incident type 2 diabetes (T2D) and metabolic syndrome (MetS) among patients with nonalcoholic fatty liver disease (NAFLD) is poorly known. We gauged the risk of developing T2D and MetS in patients with NAFLD diagnosed by either serum liver enzymes (am...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Journal of gastroenterology and hepatology Ročník 31; číslo 5; s. 936 - 944
Hlavní autori:	Ballestri, Stefano, Zona, Stefano, Targher, Giovanni, Romagnoli, Dante, Baldelli, Enrica, Nascimbeni, Fabio, Roverato, Alberto, Guaraldi, Giovanni, Lonardo, Amedeo
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	Australia Blackwell Publishing Ltd 01.05.2016
Predmet:	Alanine Transaminase - blood ALT Aspartate Aminotransferases - blood AST Biomarkers - blood Chi-Square Distribution Clinical Enzyme Tests Diabetes Diabetes Mellitus, Type 2 - diagnosis Diabetes Mellitus, Type 2 - epidemiology gamma-Glutamyltransferase - blood GGT Humans Incidence Liver enzymes Metabolic Syndrome Metabolic Syndrome - diagnosis Metabolic Syndrome - epidemiology NAFLD Non-alcoholic Fatty Liver Disease - blood Non-alcoholic Fatty Liver Disease - diagnostic imaging Non-alcoholic Fatty Liver Disease - epidemiology Prognosis Risk Assessment Risk Factors Time Factors Ultrasonography AST NAFLD GGT Metabolic Syndrome Ultrasonography ALT Liver enzymes Diabetes
ISSN:	0815-9319, 1440-1746, 1440-1746
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!